PLSH (Panacea Life Sciences Holdings) Tariff Resilience Score: 6/10 (As of Jun. 26, 2026)


What is Panacea Life Sciences Holdings Tariff Resilience Score?

Panacea Life Sciences Holdings PLSH Tariff Resilience Score is 6 as of Jun. 26, 2026. The stock has 6 warning signs investors should review. Among 1,031 Drug Manufacturers companies, Panacea Life Sciences Holdings ranks better than 90.98% on this metric.

Panacea Life Sciences Holdings has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Panacea Life Sciences Holdings has Panacea Life Sciences has a domestic focus with some international sales. Its supply chain is moderately exposed to tariffs, but the company can leverage alternative suppliers. The industry has some exemptions, reducing overall vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Panacea Life Sciences Holdings might have Average Resilient.

Panacea Life Sciences Holdings  (OTCPK:PLSH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Panacea Life Sciences Holdings Tariff Resilience Score Related Terms

PLSH vs NPHC, OWPC, CBDY: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panacea Life Sciences Holdings's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Life Sciences Holdings Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panacea Life Sciences Holdings's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Panacea Life Sciences Holdings's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 6 mean?
Panacea Life Sciences Holdings (PLSH) has a Tariff Resilience Score of 6 as of Jun. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Panacea Life Sciences Holdings ranks #93 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 9%.
Is Panacea Life Sciences Holdings' Tariff Resilience Score too high?
Panacea Life Sciences Holdings' current Tariff Resilience Score is 6. Based on the distribution chart, Panacea Life Sciences Holdings ranks #93 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Panacea Life Sciences Holdings' Tariff Resilience Score compare to NPHC and OWPC?
According to the Drug Manufacturers industry distribution chart, Panacea Life Sciences Holdings ranks #93 out of 1031 companies for Tariff Resilience Score. This places Panacea Life Sciences Holdings in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Panacea Life Sciences Holdings's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Tariff Resilience Score of 6. The current Tariff Resilience Score is 6. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Tariff Resilience Score is 6 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.